By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Babraham Research Campus

Babraham  Cambridge  CB22 3AT  United Kingdom
Phone: 44-0-1223-496190 Fax: 44-0-1223-496191



Company News
Eurostars Grant Awarded To International Consortium Including Abzena, Antitope, For Development Of Novel Treatment For Clotting Disorders 1/18/2016 9:23:00 AM
Abzena Subsidiary Antitope, INSERM And Baylor Institute For Immunology Research To Collaborate To Produce Manufacturing Cell Lines For Two Novel Vaccines For HIV 1/12/2015 11:39:02 AM
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014 10:47:32 AM
PolyTherics And Antitope Join Forces To Form Abzena, Company Picks Cambridge, UK For New Home 5/23/2014 6:27:25 AM
PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals 7/26/2013 7:53:30 AM
Antitope Announces Protein Deimmunisation Research Agreement With Research Corporation Technologies 4/23/2013 11:29:59 AM
Antitope and Eden Biodesign Enter Into a Research Agreement 2/6/2013 10:35:26 AM
Antitope and Rottapharm/Madaus AG Complete Successful Immunogenicity Assessment Research Collaboration 1/31/2013 11:00:24 AM
Antitope Announces Protein Deimmunisation Research Agreement With NeuroPhage Pharmaceuticals, Inc. 1/25/2013 9:49:17 AM
Antitope, Announces Antibody Research Agreement with Therapure Biopharma Inc. 11/7/2011 9:24:28 AM